Modulation of the Th1/Th2 balance by infliximab improves hyperthyroidism associated with a flare-up of ulcerative colitis.
Matsumura
Kayoko
K
Nakase
Hiroshi
H
Yamamoto
Shuji
S
Yoshino
Takuya
T
Takeda
Yasuhiro
Y
Kasahara
Katsuhiro
K
Ueno
Satoru
S
Uza
Norimitsu
N
Chiba
Tsutomu
T
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003093:Colitis, Ulcerative / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000209:etiology* / Q000276:immunology; D000069285:Infliximab; D018417:Th1 Cells / Q000187:drug effects / Q000276:immunology; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab